chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Left armpit aching; left breast started aching; Shoulder ache; Lymph node tender on left side; This is a spontaneous report from a contactable consumer (patient).   A non-pregnant 67-year-old female patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in arm left on 25Feb2021 13:15 (at the age of 67 years old) as dose 2, single for COVID-19 immunisation. The patient previously received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration, administered on arm left on 04Feb2021 13:00 (at the age of 67 years old) as dose 1, single for COVID-19 immunisation. Medical history included sulfa drugs allergy and breast lift and implants (silicone gel implant, May2010). Concomitant medications were not reported. On 25Feb2021 20:00, the patient experienced left armpit aching, left breast started aching, shoulder ache, and lymph node tender on left side. It was reported that the injection site was fine. The facility type vaccine was reported as other. There was no other vaccine in four weeks. Prior to COVID, patient had no vaccination and not COVID tested post vaccination. There was no treatment for the adverse events. The outcome the events was not recovered.   The lot number for BNT162B2, was not provided and will be requested during follow up.
shingles diagnosed same side of body of where she got both COVID vaccines, 23 days after getting 2nd  vaccine
Severe local reaction - red, raised approx 2 inches wide - warm to touch  lasted 5 days - resolving slowly.
Received call from pt 11.10.15 states she had rash on Lt arm under her breast and around to her back. Has morning headache and nausea for last week - Pt had Flu vaccine and Tdap in same arm. Vaccines given on 11.2.15. Is still home sick.
Red arm; swollen warm arm; Red arm; swollen warm arm; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  An elderly female patient received bnt162b2 (BNT162B2), administration date Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE JOINT ERYTHEMA (non-serious), ERYTHEMA (non-serious) all with onset 04May2021, outcome "unknown" and all described as "Red arm"; PERIPHERAL SWELLING (non-serious), LIMB DISCOMFORT (non-serious) all with onset 04May2021, outcome "unknown" and all described as "swollen warm arm".  Additional information: DR reports patients with side effects of COVID vaccine. DR: One of the things we are seeing is a red, swollen, warm arm that can start even a week later after the shot, but, um, it's not dangerous. The causality was reported as related.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Regarding  Health on the following COVID Vaccine Moderna. Please see the following determination; Doses Administered from 4.6.2021 to 5.21.2021:Based on the information you have provided and the lack of temperature data, we are not able to conduct an analysis or guarantee the doses administered between 4/6/2021 and 5/21/2021 provided the necessary protection against a COVID-19 infection. Please continue with the original plan of action on revaccination and completing a VAERS Reports on the all clients you have identified.
Booster; She has no feeling on the upper part of her tongue; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Manufacturer Unknown), for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 2021, outcome "unknown", described as "Booster"; TONGUE DISCOMFORT (non-serious) with onset 2021, outcome "not recovered", described as "She has no feeling on the upper part of her tongue".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient experienced extreme fatigue for 1 week after 2nd COVID Pfizer vaccine and about 6 weeks later on routine Accutane testing showed thrombocytopenia with platelet count of 50K.  1 month later this resolved.  No other labs abnormalities. No history low platelets or ITP.  Has family history of autoimmune conditions (Type 1 diabetes in sister and both parents with thyroid disease) and patient has subclinical/stable Hashimoto's thyroiditis.  As a dermatologist I have never observed low platelet during accurate treatment in the past 20 years.
Missed the second dose of Vivotif; Spontaneous report received on 20FEB2020.  A pharmacist reported that a female consumer "missed the second dose of Vivotif" (PT: Product dose omission) while being on Vivotif for immunisation. On 17FEB2020, the consumer took her first dose of Vivotif. It was reported that the consumer missed the second dose of Vivotif which was due on 19FEB2020. Action taken with Vivotif with respect to the reported event was not applicable. The clinical outcome of the reported event was unknown.  Company Comment: A consumer missed the second dose of Vivotif (missed dose). Vivotif should be taken every other day and the causality of missed dose is assessed as not applicable to Vivotif.; Sender's Comments: A consumer missed the second dose of Vivotif (missed dose). Vivotif should be taken every other day and the causality of missed dose is assessed as not applicable to Vivotif.
Gave Hep B and Typhoid vaccine in left arm; move to right side and administered Hep A and Tetanus/Diph. As I'm about to give yellow fever vaccine, client became unresponsive, eyes rolled back, color pale, diaphoretic. Within 15 sec. client became responsive but c/o of "knot in throat", neck pain, and spots in line of vision. B/P and pulse monitored.
Beginning 12 hours after vaccination, woke with headache, pain in hip points which became leg pain during that first day. I mostly slept that day. I tried a hot Epsom salts bath, yoga, ginger tea. Started to feel slight relief after 16 hours of great discomfort. The second day, it moved to soreness behind shoulders only, but I had plenty of energy. The third day, it became soreness in back only, and I walked a couple miles. It resolved by the next day.
an adult patient today was administered a pediatric dose of Engerix-B; an adult patient today was administered a pediatric dose of Engerix-B; an adult patient today was administered a pediatric dose of Engerix-B/first dose was administered in 2012; This non-serious case was reported by a other health professional via call center representative and described the occurrence of underdose in a 53-year-old male patient who received HBV (Engerix B pediatric) (batch number EM9E4) for prophylaxis.   Previously administered products included Engerix B (1st dose was administered in 2012).   On 27-JUL-2023, the patient received the 2nd dose of Engerix B pediatric. On 27-JUL-2023, an unknown time after receiving Engerix B pediatric, the patient experienced underdose (Verbatim: an adult patient today was administered a pediatric dose of Engerix-B), adult use of a child product (Verbatim: an adult patient today was administered a pediatric dose of Engerix-B) and drug dose administration interval too long (Verbatim: an adult patient today was administered a pediatric dose of Engerix-B/first dose was administered in 2012). The outcome of the underdose, adult use of a child product and drug dose administration interval too long were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 27-JUL-2023 The reporter was an office manager. The reporter consented to follow up via email. The Vaccine Administration Facility was the same as Primary Reporter. An adult patient was administered a pediatric dose of Engerix-B as 2nd dose later than the recommended schedule, which led to underdose and adult use of a child product and lengthening of vaccination schedule.
Dizzy; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 06Apr2021 at 12:00 (at the age of 64-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 02:00, the patient experienced dizzy. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event dizzy was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Information has been received from a pharmacist referring to a patient of unknown age and gender. There was no information regarding concomitant medication, medical history or drug reactions/allergies. On an unknown date, the patient was vaccinated with ZOSTAVAX 19400 PFU (lot #, expiration date, dose and route were unknown). On an unspecified date after administration, the patient reported an injection site reaction, which was described as being a rash and redness around the injection site that lasted for an unspecified amount of time. The outcome of the events and the causality were not reported. Additional information has been requested.
September 12 in the afternoon, I started feeling kind of tired but that was really about it. I never had a cough and maybe a little congested. September 13th I tested positive for Covid on one of the at-home tests. I notified my Doctor and he referred me to do the infusion on September 18th. I felt better after the infusion. Other than that I had a slight headache, was a little stuffy, and it was incredibly mild. I was really myself again by September 20.
Pt Admitted 08232 presents via EMS w respiratory distress, covid + 8/19, admitted and received monoclonal antibodies, sent home w 2L NC. today found O2 sat in 80's on 2L, no change on 6L, better to 90's on 15L nonrebreather. pt alert  Was doing well until today when noticed pulse ox was running in 80s and tachypneic, also noted lower flank to almost hip pain on left. Bumped O2 up but stayed low 90s, called EMS and found to be hypoxic.  Placed on 55L when in ED and I got a repeat ABG  -paO2 still 49 - now on bipap. Says she just can't catch her breath or take a deep breath. I do not see a PE on CTA but do see COVID changes, although not so severe to cause this level of hypoxia.
fever; CHILLS; HEADACHE; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (CHILLS) and HEADACHE (HEADACHE) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 012M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MELOXICAM and IBUPROFEN for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced PYREXIA (fever), CHILLS (CHILLS) and HEADACHE (HEADACHE). At the time of the report, PYREXIA (fever) and CHILLS (CHILLS) had resolved and HEADACHE (HEADACHE) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Additional concomitant medications reported included 2 heart medications and a cholesterol medication since unknown start dates for unknown indications.  Treatment medication reported included acetaminophen (Tylenol) for headache since 09-Mar-2021.
has not been well since her booster/sick from the booster for a week/not able to leave the house, not even to walk the dog more than a short way; digestive issues kept her from leaving the house for 8 days; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (has not been well since her booster/sick from the booster for a week/not able to leave the house, not even to walk the dog more than a short way) and DYSPEPSIA (digestive issues kept her from leaving the house for 8 days) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for Prophylactic vaccination.    Co-suspect products included non-company products AGALSIDASE BETA for Fabry's disease and VENLAFAXINE HYDROCHLORIDE for Depression and Anxiety.    Concurrent medical conditions included Topical adhesive reaction, Dermatitis contact, Depression, Anxiety, Insomnia, Dizziness (She got dizzy and felt like she had to lie down or shoe would fall over), Pain (it was the pain that she had the last few infusions), Feeling abnormal, Pruritus, Fabry's disease, Panic attack, Nasopharyngitis and Eye disorder. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Premedication.   On 20-Oct-2015, the patient AGALSIDASE BETA (IV drip) dosage was changed to 100 milligram. On 01-Apr-2021, AGALSIDASE BETA (IV drip) dosage was changed to 100 milligram. On 08-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form, AGALSIDASE BETA (IV drip) 100 milligram and VENLAFAXINE HYDROCHLORIDE (unknown route) at an unspecified dose. On 08-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MALAISE (has not been well since her booster/sick from the booster for a week/not able to leave the house, not even to walk the dog more than a short way). In October 2021, the patient experienced DYSPEPSIA (digestive issues kept her from leaving the house for 8 days). At the time of the report, MALAISE (has not been well since her booster/sick from the booster for a week/not able to leave the house, not even to walk the dog more than a short way) outcome was unknown and DYSPEPSIA (digestive issues kept her from leaving the house for 8 days) had resolved.            No treatment medications were provided by the reporter  Patient said that she had not been well since her booster shot on Friday (malaise) 08-oct-2021, patient was sick from the booster for a week and digestive issues kept her from leaving the house for 8 days. She had not been able to leave the house, not even to walk the dog more than a short way.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked in.   This case was linked to MOD-2021-624460 (Patient Link).   Reporter did not allow further contact
Child received Flu vaccine while sitting in mother's lap immediately after she stood up & fell to floor, with back arched, arms drawn in & eyes rolled back with what appeared to be a possible seizure. Mother took her to see PCP that evening. He diagnosed with seizure & trauma response to injection. She has had 4 similar responses in past 10 months. To get FLUMIST in future & notify healthcare providers of responses to trauma.
Reported Symptoms: 10002218: ANAPHYLAXIS; 10002424:ANGIOEDEMA; 10013573:DIZZINESS; 10037844:RASH; 10046735:URTICARIA; Narrative: Per 12/7 ED provider note: 62 yo male with the chief complaint of Possible allergic reaction.  The patient states that he received the pneumococcal vaccine in his primary clinic today, shortly after hebegan to have a "tingling" sensation all over his body, he feels as though he may have a rash, and feels as thought his tongue is "a little swollen." He denies nausea or vomiting, he denies abdominal pain, he is not wheezing but states he is mildly short of breath.
Varicella - Information has been received from a registered nurse concerning a 5 year old female who at the age of 1 was vaccinated with one dose of varicella virus vaccine live (unknown site).  On 27 Apr 2000, the reported indicated that the patient has now developed varicella with approximately 100 lesions.  The patient sought unspecified medical attention.  Also reported was the patient brother who was vaccinated and experienced a similar event (waes 00042793).. Additional information has been requested.
1st Inj - immediately tasted a metallic taste; swelling of the throat; swelling of the throat, lips; swelling of the throat, lips and tongue; hard to swallow; joint pain; headaches; feeling unwell; tiredness; some itching; This is a spontaneous report received from a contactable consumer, the patient. A 51-years-old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 m-RNA VACCINE,Formulation: Solution for injection, Lot number: ER8733), via an unspecified route of administration, in arm left on 01Apr2021 at 09:30 as Dose 1, Single (at the age of 51-year-old) for Covid-19 immunization. Medical history included allergy to Penicillin and Vicodin. The patient did not take any other vaccine in four weeks or any other medications in two weeks. The patient did not receive any other medications within 2 weeks of vaccination. The patient's concomitant medications were not reported. The patient, after first injection, on 01Apr2021, immediately tasted a metallic taste, had swelling of the throat, lips and tongue, hard to swallow ( all of these w/in the first 5 mins), had joint pain, headaches, was feeling unwell, tiredness, some itching. The patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 m-RNA VACCINE, Formulation:Solution for injection, lot number: EW0169), via an unspecified route of administration, in arm left on an unknown date in Apr2021 at as Dose 2, Single for covid-19 immunization. Therapeutic measures were taken as a result of the events, the patient was advised to take Benadryl and received Benadryl an hour after appt. The events resulted in Doctor or other healthcare professional office/clinic visit. It was unknow n if the patient had if covid prior vaccination. She was not covid tested post vaccination. It was unknown if prior to vaccination, the patient was diagnosed with COVID-19 or not. Since the vaccination, the patient has not been tested for COVID-19. The outcome of all the events was recovered with lasting effects.  Information on the lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
Post menopause for 22 months and got a full period 10 days after receiving 2nd vaccination.  Needed to rule out cancer, so started with PAP, blood work, and MAMM.  PAP came back abnormal, ultrasound and biopsies scheduled.  MAMM came back abnormal needing diagnostic 3D imaging.  Needed MRI of Pelvis for additional determination of abnormal result.  Then had to have ultrasound on right breast.  All biopsies and tests came back benign. Still experiencing hot flashes, night sweats, and extreme emotions - did not have these symptoms in the past 2 years with prescribed medication when going through menopause.
The evening of 11/17/99 the pt was crying, pale, limp, and unresponsive, and had 3 short periods of LOC. Hypotonia, fever, injection site erythema, injection site mass. Leukocytes = 21000, hemoglobin=134 g/l, platelets=183000. See original
2/26/2021- Trouble regulating body temp, headache, sore throat, loss of voice, slight cough, fatigue, stuffy nose, runny nose  2/27/2021- trouble regulating body temp, headache, sore throat, bad cough (that causes pain in throat, chest and upper back), stuffy nose, runny nose, aching joints, fatigue
This spontaneous report as received from certified medical assistant and refers to a female adult patient of unknown age. The patient had the MMR II (dose, strength not reported), series on unspecified dates as a child (dates not provided). On an unknown date the patient had titers drawn which showed "less than normal" titers for mumps. The outcome of "less than normal" titers for mumps was reported as not recovered/not resolved. The relatedness between event and MMR II was not reported. Additional information has been requested.
tired; Muscle ache; stuffy nose; got cold, so cold; Chills/so cold her teeth were chattering; uncontrollable shaking; sore arm; This is a spontaneous report from a contactable consumer (patient).  A 53-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EW0164), via an unspecified route of administration, administered in arm left on 22Apr2021 at 06:20 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included sinus infection and colonoscopy from an unknown date and unknown if ongoing. The patient's concomitant medication included daily vitamin (unspecified). The patient previously took bnt162b2 for COVID-19 immunisation on 18Mar2021 (at the age of 53-years-old) and experienced sore arm, muscle aches, tired, stuffy nose, had been exposed to COVID, an upset stomach, chills, worst headache and had no energy. The patient also previously took oxytocin (PITOCIN) and experienced uncontrollable shaking. It was reported that her arm got sore pretty quickly after the second dose on 22Apr2021. The sore arm is ongoing. Her arm is killing her. It was ok, she took the Advil. She didn't think she felt that bad. She could tell she would be tired last night from it. Then she got cold. The heat was on 70 and she got cold and had chills and shaking and couldn't stop. When she woke up this morning (23Apr2021), she had other muscle aches and stuffy nose. She feels a little tired this morning. She thinks that will be gone in a day or so. The patient underwent lab tests and procedures which included oxygen saturation: fine on an unspecified date. Therapeutic measures were taken as a result of chills/so cold her teeth were chattering and sore arm. The outcome of the event sore arm was not recovered; chills/so cold her teeth were chattering and uncontrollable shaking was recovered on 22Apr2021, while of the rest was unknown.
I started bleeding vaginally 8 days earlier than my period usually would start. I am usually like clockwork, but I began my period 8 days early.
Known allergic reactions-requesting vaccine.  Had personal EpiPen with her.  Itchy throat, watering eyes.
This spontaneous report as received from a consumer refers to a 17-year-old female patient (daughter). The patient states that her daughter had GARDASIL administered improperly. On an unknown date in September 2011 the patient was vaccinated with dose 2 GARDASIL (lot#, expiration date and route not reported). No concomitant medications were reported. The patient was vaccinated with dose 1 GARDASIL (lot#, expiration date and route not reported) according to the schedule on an unknown date. Patient took second dose late and never took the 3rd dosage. Medical attention was not sought by the patient. Additional information has been requested.